28 May 2021 - EMA’s CHMP has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use ...
27 May 2021 - EMA’s COVID-19 taskforce is advising health care professionals that there is currently insufficient evidence that inhaled ...
26 May 2021 - A lawyer for the European Union has accused AstraZeneca of failing to respect its contract with ...
21 May 2021 - The EMA on Friday recommended extending conditional marketing approval by a year for Gilead Sciences’ COVID-19 ...
20 May 2021 - New agreement to supply 900 million doses to the European Commission, with option to request up to ...
21 May 2021 - EMA’s CHMP has completed its review on the use of the monoclonal antibody sotrovimab (also known as ...
21 May 2021 - EMA has provided additional advice on blood clots or low blood platelets occurring after vaccination with Vaxzevria ...
17 May 2021 - EMA’s CHMP has recommended a change to the approved storage conditions of Comirnaty, the COVID-19 vaccine ...
11 May 2021 - EMA is implementing additional temporary measures to further streamline activities in the European medicines regulatory network ...
7 May 2021 - EMA’s CHMP has started a ‘rolling review’ of data on sotrovimab (also known as VIR-7831 and ...
4 May 2021 - EMA’s CHMP has started a rolling review of COVID-19 Vaccine (Vero Cell) inactivated, developed by Sinovac ...
26 April 2021 - The European Union has sued AstraZeneca over what the bloc has described as delays in shipping ...
26 April 2021 - The EMA and the European Centre for Disease Prevention and Control today kicked off a new ...
23 April 2021 - Vaxzevria (formerly COVID-19 Vaccine AstraZeneca) is authorised in the EU to prevent COVID-19, which can cause ...
23 April 2021 - EMA’s human medicines committee (CHMP) has adopted two important recommendations that will increase manufacturing capacity and supply ...